OpportunityTitle: Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following: Only the current START awardee is eligible to apply to this limited competition FOA.
Description: The purpose of this limited competition Funding Opportunity Announcement (FOA) is to continue support to complete the Strategic Timing of Antiretroviral Treatment (START) trial. START is a randomized clinical trial to determine if immediate initiation of antiretroviral treatment (ART) in HIV-positive patients is superior in delaying the occurrence of AIDS, non-AIDS events and death.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;